Table 1 Perioperative period results and follow-up data of all 11 patients
No. | Sex/age | Operation date | Disease | Tumor size (mm) | Operation time (min) | Vascular clamp | Blood loss (mL) | RBC transfusion (units) | Postoperative complications | Hospital stay (d) | DFS | OS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M/58 | 2015.04 | HCC | 45 | 230 | PTC for 20 min | 360 | 1 | None | 13 | 3 years 10 months Intrahepatic recurrence | 5 years 2 months |
2 | M/63 | 2015.05 | HCC | 40 | 210 | TVE for 15 min | 400 | 1.5 | Pleural effusion | 12 | No recurrence 5 years 5 months | – |
3 | M/56 | 2016.03 | HCC | 35 | 180 | 280 | None | 10 | 4 years 2 months Intrahepatic recurrence | – | ||
4 | M/74 | 2016.10 | CRLM | 25 | 240 | PTC for 15 min + 12 min | 450 | 2 | Grade A bile leaks | 14 | 2 years 11 months Lung metastases | 3 years 9 months |
5 | M/59 | 2017.05 | HCC | 33 | 170 | 230 | Wound hematoma | 16 | 1 years 8 months Bone metastases | 2 years 4 months | ||
6 | M/73 | 2017.09 | HCC | 47 | 160 | 260 | None | 7 | No recurrence 3 years 1 months | – | ||
7 | W/71 | 2018.02 | HCC | 40 | 180 | 340 | 1 | None | 9 | No recurrence 2 years 8 months | – | |
8 | W/58 | 2018.04 | CRLM | 28 | 200 | PTC for 17 min | 280 | None | 8 | 2 years 2 months Lung metastases | – | |
9 | M/67 | 2018.09 | HCC | 38 | 160 | PTC for 10 min | 220 | Pleural effusion | 10 | No recurrence 2 years 1 months | – | |
10 | M/56 | 2019.02 | HCC | 30 | 180 | PTC for 12 min | 200 | Grade A bile leaks | 13 | No recurrence 1 years 8months | – | |
11 | W/63 | 2019.9 | HCC | 34 | 160 | PTC for 15 min | 150 | None | 8 | No recurrence 1 years 1 months | – |